BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  BioSpace, Inc.

  BioSpace is the hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
• 

  Government

  Vertex Reaches Reimbursement Deal with UK for Casgevy Gene Therapy in Thalassemia

  Patients in the U.K. with transfusion-dependent beta-thalassemia will have access to Vertex Pharmaceuticals’ gene editing therapy Casgevy, thanks to an agreement with the National Health Service on the price.

  August 8, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  IgA nephropathy

  Novartis’ Fabhalta Gets FDA Accelerated Approval, Becomes First Complement Inhibitor for IgAN

  Fabhalta is approved for the treatment of IgAN patients who are at risk of rapid disease progression, which is indicated by a urine protein-to-creatinine ratio of at least 1.5 g/g.

  August 8, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Lung Cancer

  Merck Halts Phase III Trial of Keytruda, Anti-TIGIT Combo in Small Cell Lung Cancer

  The pharma said Thursday it is stopping a late-stage study of its blockbuster Keytruda plus the anti-TIGIT antibody vibostolimab and chemotherapy as a first-line treatment for extensive-stage small cell lung cancer, following a recommendation from an independent data monitoring committee.

  August 8, 2024

   · 

  2 min read

   · 

  Tyler Patchen
• 

  Job Trends

  9 Life Sciences Companies Hiring in Texas

  Looking for a job in Texas? Check out these nine companies hiring life sciences professionals like you.

  August 8, 2024

   · 

  1 min read

   · 

  Angela Gabriel
• 

  Career Advice

  The Ph.D. Debate: Should Scientist Roles Require Ph.D.s?

  A BioSpace LinkedIn poll showed that just 19% of respondents believe biopharma professionals need Ph.D.s for scientist roles.

  August 8, 2024

   · 

  3 min read

   · 

  Angela Gabriel
• 

  Earnings

  Lilly Beats Q2 Expectations as Tirzepatide Supply Stabilizes, Raises Full-Year Revenue Guidance by $3B

  Eli Lilly comfortably cleared analyst estimates in the second quarter after improving supply of its blockbuster tirzepatide brands Mounjaro and Zepbound, which together generated more than $4 billion in sales.

  August 8, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Mergers & acquisitions

  Recursion, Exscientia Merge to Create AI-Enabled Biotech

  Armed with a combined $850 million in cash, the companies said Thursday the resulting biotech will have a pipeline that could deliver 10 clinical readouts over the next 18 months.

  August 8, 2024

   · 

  2 min read

   · 

  Nick Paul Taylor
• 

  Career Advice

  Companies Increasingly Demand Specialized Skill Sets

  Employers have adjusted to higher salaries. That also means they’ve become adamant they get specific skill sets, according to Greg Clouse, BioSpace recruitment manager.

  August 8, 2024

   · 

  3 min read

   · 

  Angela Gabriel
• 

  Parkinson’s disease

  Amneal Wins FDA Approval for Extended-Release Oral Parkinson’s Drug

  Crexont was previously rejected by the regulator in June 2023, citing insufficient safety data. However, Amneal Pharmaceuticals’ resubmission included findings from a healthy volunteer study.

  August 8, 2024

   · 

  2 min read

   · 

  Tristan Manalac